Barcelona

Barcelona 8035

1 studies enrolling now · 10 studies all time

What they study most

Cirrhosis, Eye Diseases, Heart Failure With Preserved Ejection Fraction, Hepatitis C, Hypertension, Pulmonary, Lung Diseases, Interstitial, Non-alcoholic Steatohepatitis, Parkinson Disease, Portal Hypertension, Prostate Cancer, Pulmonary Hypertension, Seizures

Studies at this site

• Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease — Recruiting now
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Running, not enrolling
• Open-label Trial in Parkinson's Disease (PD) — Completed
• Fixed-Dose Trial in Early Parkinson's Disease (PD) — Completed
• A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Completed
• Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) — Completed
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer — Completed
• A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) — Stopped early
• Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation — Completed